Related by context. All words. (Click for frequent words.) 67 Factor VIIa 66 PDE4 inhibitor 66 THR beta agonist 65 metaglidasen 65 liposomal formulation 65 ATL# [002] 64 UPLYSO 64 volociximab 64 Trofex 64 targeted radiotherapeutic 64 IAP inhibitor 64 CCX# 64 orally administered inhibitor 64 sargramostim 64 lexidronam injection 64 MKC# MKC# PP 63 gefitinib Iressa 63 MKC# 63 cholesteryl ester transfer 63 XP# XP# 63 Ecallantide 63 novel VDA molecule 63 Mipomersen 63 DURIN TM 63 intranasal formulation 63 rxRNA 63 oral picoplatin 63 Panzem R 63 Aliskiren 63 uricase 63 factor VIIa 63 Zemiva TM 63 rNAPc2 63 reslizumab 63 JAK inhibitor 63 Civacir 63 MKC# MT 63 Generx ™ 62 ALGRX 62 RhuDex ® 62 MEK inhibitor 62 Personalized Immunotherapy 62 ularitide 62 MAGE A3 ASCI 62 PRT# 62 intravenous recombinant 62 selective modulator 62 tiapamil 62 elotuzumab 62 Xyfid TM 62 candesartan cilexetil 62 ENMD # 62 Phase IIa trials 62 orally dosed 62 CB2 selective receptor agonist 62 MYDICAR 62 inhibitor RG# 62 IV Busulfex 62 Panzem NCD 62 AEGR 62 selective antagonist 62 investigational humanized monoclonal antibody 62 mertansine 62 Nektar proprietary 62 Adenoscan R 62 GW# [003] 62 histone deacetylase HDAC inhibitor 62 RELOVAIR ™ 62 Clolar ® 62 vascular disrupting agents 62 Silodosin 61 molecular imaging radiopharmaceutical 61 Augment TM 61 oral prodrug 61 Lixivaptan 61 HepDirect prodrug 61 R#/MEM # 61 urocortin 2 61 opioid induced bowel dysfunction 61 RTP #i 61 ADP receptor antagonist 61 Xanafide 61 aurora kinase 61 Tezampanel 61 multicenter Phase II 61 Xcytrin R 61 INT# [002] 61 bardoxolone 61 fosbretabulin 61 Alfacell proprietary ribonuclease 61 ALN TTR 61 Zemiva ™ 61 PEG uricase 61 histone deacetylase inhibitor 61 pioglitazone HCl 61 novel oral anticoagulant 61 Elagolix 61 PrevOnco 61 catheter occlusion 61 CYT# potent vascular disrupting 61 Generx TM 61 phase III isavuconazole 61 BRILINTA 61 ARIKACE ™ 61 XL# XL# XL# 61 Degarelix 61 dihydrochloride 61 Squalamine 61 Inhalation Solution 61 Anavex #-# 61 AzaSite Plus 61 highly selective inhibitor 61 thetreatment 61 cannabinor 61 HQK 61 Mg Usa 61 CD# CEA 61 topically administered 61 vinorelbine tartrate 61 docetaxel Taxotere R 61 GAMMAGARD 61 CCR5 mAb 61 metastatic malignant 61 targeted antifolate 61 Initiate Clinical Trial 61 Triolex 61 novel histone deacetylase 61 neuronal nicotinic receptor NNR 61 AEG# 61 NB S# strontium malonate 61 oncolytic virus therapies 61 Oral NKTR 61 Daclizumab 61 SYN# 61 Phenoptin 61 PDX pralatrexate 61 MTP inhibitor 61 either acutely decompensated 61 Meets Primary Endpoint 60 Hsp# Inhibitor 60 DUROS 60 Onconase 60 hypoxia activated prodrug 60 Phase 2a Clinical Trial 60 HuMax 60 HCD# [002] 60 Kahalalide F 60 IMPDH inhibitor 60 BLP# Liposome Vaccine 60 6R BH4 60 hoFH 60 ALN PCS 60 Liposomal 60 Initiates Clinical 60 PLK1 SNALP 60 Phase IIb clinical trials 60 OvaRex R 60 AAG geldanamycin analog 60 Leukine ® 60 Vidaza ® 60 PSMA ADC 60 selective androgen receptor modulator 60 Thrombin 60 cortisol synthesis 60 HDAC Inhibitor 60 topical ophthalmic 60 isoform selective 60 non nucleoside inhibitor 60 Dose Ranging Study 60 Vascular Wrap TM 60 Qutenza TM 60 GV# [001] 60 induced macular edema 60 Pimavanserin 60 MAP# 60 Radezolid 60 EndoTAG 60 GLP1 agonist 60 kidney urologic 60 MGd 60 pain palliation 60 Phase III Pivotal 60 OvaRex ® MAb 60 phase IIb clinical 60 Myocet 60 YONDELIS 60 HCV polymerase 60 TNF Tumor Necrosis Factor 60 integrin inhibitor 60 Veronate R 60 aripiprazole Abilify 60 hyaluronidase enzyme 60 dasatinib Sprycel 60 pan HDAC inhibitor 60 Preclinical studies suggest 60 LAF# 60 Vidaza R 60 Aurora Kinase 60 Parathyroid Hormone 60 ATPace TM 60 Glypromate 60 Archexin 60 XL# anticancer compounds 60 Aflibercept 60 Files IND 60 Azedra TM 60 HuLuc# 60 BAY #-# 60 NV1FGF 60 Completes Patient Enrollment 60 Technosphere ® 60 Iluvien ® 60 EVIZON TM squalamine lactate 60 Ad5FGF 4 60 Bruton tyrosine kinase Btk 60 TLK# 60 INCB# [001] 60 inhalation aerosol 60 treat chronic sinusitis 60 HDL Selective Delipidation 60 beta 1a 60 Bendavia 60 Iloperidone 60 eprotirome 60 ORENCIA R 60 cysteamine bitartrate 60 cathepsin K inhibitor 60 Angiotensin Converting Enzyme 60 CYP#A# CYP#D# 60 IV APAP 60 aldehyde dehydrogenase ALDH2 deficiency 60 Phase #b/#a clinical 60 Novolimus 60 AQ4N 59 XL# XL# 59 ILUVIEN ® 59 personalized immunotherapy 59 PSN# [002] 59 Solazed 59 davalintide 59 reversible inhibitor 59 TLR9 agonist 59 generation purine nucleoside 59 SGLT2 inhibitors 59 nitric oxide donating prostaglandin 59 dyskinesia PD LID 59 intravenous acetaminophen 59 FOLOTYN ® 59 topoisomerase II inhibitor 59 FBPase 59 acetonide FA 59 orally bioavailable 59 Syncria R 59 Methylnaltrexone 59 Zorbtive TM 59 rusalatide acetate 59 Solazed TM 59 KRN# 59 receptor tyrosine kinase inhibitor 59 Drug Candidate 59 Zenvia ™ 59 albiglutide 59 small molecule activators 59 siRNA therapeutic 59 Augment ™ 59 INTEGRILIN 59 somatostatin analogue 59 vidofludimus 59 Marqibo TM 59 TBC# 59 cromolyn sodium 59 PF # [002] 59 Pafuramidine 59 Dasatinib 59 JAK2 inhibitor 59 NGX# 59 Presents Preclinical 59 PANVAC VF 59 Orally administered 59 Proellex TM 59 HCV protease inhibitor 59 sevelamer carbonate 59 PEG SN# 59 Fondaparinux 59 Initiates Phase II 59 topically applied SEPA 59 ULTRASE 59 endothelin antagonist 59 protein tyrosine phosphatase 1B 59 sodium thiosulfate STS 59 SERMs 59 A1PI 59 antisense drug 59 Insegia 59 Angiocept 59 Dalbavancin 59 TH# [003] 59 Tyrima 59 Kinase Inhibitor 59 docetaxel Taxotere ® 59 Sapacitabine 59 tanespimycin 59 Annamycin 59 Phase 2b Clinical Trial 59 compound ITMN 59 EXPAREL TM 59 Initiates Enrollment 59 TELCYTA 59 GVAX ® 59 REMINYL ® 59 Apixaban 59 Spiegelmer ® 59 IL# PE#QQR 59 TELINTRA 59 ISIS # 59 vapreotide acetate 59 Myolimus 59 huC# DM4 59 lucinactant 59 dasatinib Sprycel ® 59 Cleviprex TM clevidipine 59 EGFR HER2 59 Medidur ™ FA 59 PGL# 59 Saforis 59 Achieves Primary Endpoint 59 Acapodene 59 R#/MEM 59 anti angiogenic agents 59 budesonide foam 59 Omacetaxine 59 MIST II 59 Chemokine Receptor 59 Traficet EN 59 teriflunomide 59 Resten NG 59 bortezomib Velcade 59 Polymer Microspheres 59 seliciclib CYC# 59 PRN FDA Approves 59 bazedoxifene selective estrogen receptor 59 Zybrestat 59 Cloretazine VNP#M 59 AFREZZA TM 59 ZOLINZA 59 Pertuzumab 59 REG1 59 ABILIFY ® 59 2 methoxyestradiol 59 lintuzumab SGN 59 NeoLipid R 59 muscarinic receptor agonist 59 NF kB Decoy 59 sd rxRNA 59 Interferon Beta 59 PN# [001] 59 Prodarsan R 59 hyperphenylalaninemia HPA due 59 proteasome inhibitor 59 peripherally acting 59 SinuNase ™ 59 vivo validation 59 HGS# 59 overactive bladder AA# 59 selective phosphodiesterase 59 Alfimeprase 59 histone deacetylase HDAC 59 5 HT2A inverse 59 Exelixis compounds 59 Ganciclovir 59 thalidomide Thalomid 59 Aganocide 59 thrombin receptor 59 EVIZON TM 59 Medoxomil 59 acyclovir Lauriad R 59 Safinamide 59 Cardio Vascu Grow 59 Phase Ib clinical trials 59 Soliris eculizumab 59 nucleotide analog 59 PI3K/Akt pathway inhibitor 58 IMA# 58 Panzem 58 including eniluracil ADH 58 humanized monoclonal 58 XYOTAX TM 58 lomitapide 58 EZN 58 Cannabinor 58 delivery polymer matrix 58 Pivotal Phase III 58 Panzem R NCD 58 trial evaluating PRX# 58 Tasimelteon 58 pertuzumab 58 Lisofylline LSF 58 IGF 1R inhibitor 58 selective agonist 58 Chrysalin 58 non nucleoside HCV 58 sterile lidocaine patch 58 GSK# [002] 58 Aggrastat 58 EOquin TM 58 initiated Phase Ib 58 preclinical efficacy 58 CORT # 58 Cypher Sirolimus 58 PDE# inhibitors 58 cMET 58 cobiprostone 58 TPI ASM8 58 Shigamabs ® 58 prokinetic agent 58 Phase 1a clinical 58 phase IIa clinical 58 include PLX IBD 58 delivers fluocinolone acetonide FA 58 Initiates Clinical Trial 58 TKM ApoB 58 Muraglitazar 58 PS# [001] 58 erlotinib Tarceva ® 58 Inhalation Aerosol 58 Cathepsin S 58 etanercept Enbrel 58 HyperAcute 58 Pivotal Study 58 AVAPRO 58 Tesetaxel 58 NP2 Enkephalin 58 radiation sensitizer 58 ChronVac C R 58 immunotherapeutic vaccine 58 EndoTAG TM -1 58 Bezielle 58 prescribed proton pump 58 Phase Ib clinical 58 Dacogen decitabine 58 Trofex TM 58 oral proteasome inhibitor 58 inhaled AAT 58 Androxal TM 58 CDK inhibitor 58 ONCONASE R 58 M# rationally 58 oral Janus kinase 58 Apoptone 58 sodium glucose cotransporter 58 CINTREDEKIN BESUDOTOX 58 nephropathic cystinosis 58 UVIDEM 58 reduce serum phosphate 58 TRISENOX ® 58 accumulate preferentially 58 HuMax EGFr 58 romidepsin novel 58 HMG CoA reductase inhibitors 58 Pyridorin 58 Octreotide 58 Initiate Phase 58 EVIZON ™ 58 TREDAPTIVE 58 JUVISTA R Human 58 mTOR inhibitors 58 Zenvia Phase III 58 rALLy 58 Abbokinase 58 RH1 58 Darapladib 58 favorable pharmacokinetic profile 58 iobenguane 58 Zoraxel TM 58 Avanafil 58 TRIOLEX HE# APOPTONE HE# 58 Targeted Chemotherapy 58 IV acetaminophen 58 dopamine partial agonist 58 Teriflunomide 58 NeuroSTAT ® 58 alemtuzumab Campath 58 Thalomid ® 58 orally bioavailable mimics 58 histamine dihydrochloride 58 investigational monoclonal antibody 58 Crofelemer budesonide foam 58 tezampanel 58 Motavizumab 58 octreotide acetate 58 CD# monoclonal antibody 58 JAK2 Inhibitor 58 adenosine A2A 58 ARRY # 58 Transdermal Patch 58 oral Hsp# inhibitor 58 VEGF inhibitors 58 mGluR2 NAM 58 engineered anticoagulant 58 Janus kinase 58 ASTEROID 58 selective immunoproteasome inhibitor 58 Olmesartan 58 Xelox 58 entacapone 58 Phase 2b clinical trials 58 Reports Preclinical Data 58 VNP#M 58 Kamada AAT 58 pravastatin Pravachol 58 gemcitabine Gemzar ® 58 modulators SERMs 58 GEM OS2 58 sitaxsentan 58 Aplidin R 58 RNAi therapeutic targeting PCSK9 58 INS# [001] 58 Fenretinide 58 NM# [003] 58 CCR9 antagonist 58 humanized monoclonal antibody 58 MCSP respectively 58 Pivotal Phase 58 PFO migraine 58 proprietary intravenous formulation 58 MyoCell SDF 1 58 OXi# 58 Neutrolin 58 Anturol TM 58 ganetespib 58 EmbraceAC 58 mu opioid receptor antagonist 58 ALVESCO R 58 neratinib 58 small molecule tyrosine 58 iSONEP ™ 58 KSP inhibitor 58 RhuDex 58 chemically modified siRNA 58 canagliflozin 58 Anticalin ® 58 CYT# QbG# 58 compound KOS 58 Phase #b/#a trial 58 ALN TTR# 58 TAXUS Element Paclitaxel Eluting 58 midstage clinical 58 Azedra 58 Tarceva TM 58 PI3K/mTOR 58 Phase 1b clinical trials 58 brivanib 58 Retavase 58 statin simvastatin 58 Trandolapril 58 Neo Bladder Augment 58 cetuximab Erbitux R 58 trastuzumab DM1 T DM1 58 VIAtab TM 57 paclitaxel eluting 57 selective kinase inhibitor 57 Glucophage XR 57 D aspartate NMDA receptor 57 arterial thrombosis 57 Tyrosine Kinase Inhibitor 57 direct thrombin inhibitors 57 tolevamer 57 5 HT3 antagonist 57 glucagon receptor 57 Fodosine 57 Protein Kinase C 57 Initiates Phase 2b 57 Immunotherapeutic 57 Vitaxin 57 LY# [002] 57 topical formulations 57 TG# [003] 57 echinocandin 57 RSD# oral 57 successfully commercialize Iluvien 57 Amikacin Inhale 57 Sudhir Agrawal D.Phil 57 PNP inhibitor 57 chimeric monoclonal antibody 57 PEGPH# 57 ESBA# 57 anti CD3 57 HGS ETR2 57 Levoleucovorin 57 CA9 SCAN 57 Biolimus A9 57 BEMA Granisetron 57 Phase IIIb clinical 57 vorinostat 57 Albugon 57 DURECT proprietary 57 thromboxane A2 57 phase IIa 57 SGLT2 inhibitor 57 tyrosine kinase inhibitor 57 ospemifene 57 Neulasta ® 57 ruxolitinib 57 PEGylated anti 57 pharmacokinetic PK profile 57 BrachySil TM 57 leukotriene pathway 57 novel prodrug 57 Anacetrapib 57 nalbuphine ER 57 Iluvien TM 57 Intravitreal injections 57 TMC# [002] 57 fondaparinux sodium 57 confirmatory clinical 57 Aurexis 57 AERx ® 57 IMiDs R 57 topical gel formulation 57 IAP inhibitors 57 lapatinib Tykerb 57 Tekturna HCT 57 Alferon N 57 diarrhea predominant irritable 57 GSK '# 57 Fibrin Pad 57 alpha#beta# integrin 57 Presents Preclinical Data 57 brivaracetam 57 Cloretazine ® 57 HepaGam B 57 PORxin TM 57 Antiangiogenic 57 acute peripheral arterial 57 lipid lowering therapies 57 Ophthotech 57 mGluR5 negative 57 factor Xa 57 mecamylamine 57 DNA intercalator 57 BrachySil ™ 57 octreotide implant 57 Nanobody 57 generation antisense inhibitor 57 Dabigatran etexilate 57 BCX# 57 PresbyLens ® 57 Cintredekin Besudotox 57 small molecule Hedgehog 57 treat nephropathic cystinosis 57 novel emulsion formulation 57 trodusquemine 57 sorafenib Nexavar 57 sulfonylhydrazine class 57 adalimumab Humira 57 MNTX 57 CMV vaccine 57 mitogen activated ERK kinase 57 vernakalant hydrochloride 57 dutogliptin 57 treatment naive genotype 57 incyclinide 57 PEGylated Fab fragment 57 Dapagliflozin 57 Vascular Disrupting Agent 57 antiplatelet agent 57 adecatumumab MT# 57 stable nucleic acid 57 non porcine pancreatic 57 refractory chronic lymphocytic 57 Familial Adenomatous Polyposis FAP 57 ALN VSP Phase 57 Hycamtin ® 57 5 HT2C receptor 57 CG# [003] 57 mTOR inhibitor 57 ReFacto 57 intravenously administered 57 Milnacipran 57 Fibrillex TM 57 include Phenoptin TM 57 Panzem ® 57 Virulizin R 57 outlicensed 57 Saxagliptin 57 dextromethorphan quinidine 57 TELINTRA R 57 metastatic neuroendocrine tumors 57 PEGylated interferon 57 Patients Treated With 57 JAK1 57 Submits NDA 57 Interferon alfa 57 occlusion PAO 57 alvespimycin 57 VEGF Trap 57 GA GCB 57 HCV protease inhibitors 57 delta gamma agonist 57 Novel Oral 57 PEG IFN 57 antisense inhibitors 57 retinal vein occlusion induced 57 cangrelor 57 humanized anti 57 Canvaxin TM 57 Anticalin R 57 gamma secretase inhibitor 57 INSPIRE Trial Phase III 57 Amrubicin 57 BENICAR HCT 57 oral anti arrhythmic 57 monoclonal antibody MAb 57 Intermezzo ® zolpidem tartrate 57 Enkephalin 57 Valtropin 57 Nanobody ® 57 receptor partial agonist 57 Evoltra ® 57 fostamatinib disodium 57 lumiliximab 57 Pathway Inhibitor 57 drug eluting coronary stent 57 vinca alkaloid 57 Vicinium TM 57 IMiDs ® 57 p# inhibitor 57 Velcade bortezomib 57 LEP ETU 57 Cloretazine 57 itraconazole Sporanox 57 XmAb# 57 IMiDs 57 ALVESCO ® 57 Granted Orphan Drug 57 R roscovitine 57 Troxatyl 57 OMNARIS HFA 57 inhaled formulation 57 Dural Sealant 57 Ostabolin C TM 57 Pegloticase 57 Deforolimus 57 potent suppressor 57 MyVax R 57 sJIA 57 sunitinib malate 57 LymphoStat B TM 57 ELACYT 57 selectively inhibit 57 dexpramipexole 57 TRO# 57 Aviptadil 57 Replacement Therapy 57 evaluating tivozanib 57 Mg Uk 57 myelodysplastic myeloproliferative diseases 57 Investigational Oral 57 inhibitor PPI 57 huN# DM1 57 Allovectin 7 57 antifibrotic 57 Unit Dose Budesonide 57 Allovectin 7 R 57 metastatic colorectal 57 APOPTONE 57 Ridaforolimus 57 phase IIb trial 57 midstage clinical trials 57 UCB Keppra 57 bile acid sequestrant 57 Solazed ™ 56 dacetuzumab 56 pathway inhibitor 56 Cx# [002] 56 Anidulafungin 56 Olaparib 56 edifoligide 56 Solulin 56 Lenocta 56 conjugated estrogens 56 ZD# [001] 56 Pemetrexed 56 SURFAXIN r 56 quinapril 56 therapeutic monoclonal antibody 56 Receives Orphan Drug Designation 56 VEGF receptor 56 Solzira ™ 56 Bicifadine 56 KB# [002] 56 Alvesco R 56 forodesine 56 GRNCM1 56 Ambrisentan 56 polymerase inhibitor 56 Eltrombopag 56 NASH Huntington 56 JAK3 inhibitor 56 5 HT2A serotonin 56 LNP formulations 56 TKB# 56 AERx iDMS 56 AKT inhibitor 56 Completes Enrollment 56 E2F Decoy 56 anticancer compound 56 ELND# 56 Cangrelor 56 SLx 56 novel synthetic peptide 56 Delafloxacin 56 Fulvestrant 56 potent topoisomerase II 56 NS5B polymerase 56 oral Factor Xa 56 PAOD 56 Androgel R 56 DPP4 inhibitor 56 GeneICE 56 pharmacodynamic properties 56 AZD# 56 Fx #A 56 visilizumab 56 Aryplase 56 xanthine oxidase inhibitor 56 Talabostat 56 sorafenib tablets 56 LEUKINE 56 JAK#/JAK# 56 Onco TCS 56 EGS# 56 donepezil Aricept 56 ocular formulation 56 PI3K inhibitor 56 nucleoside analog 56 MYDICAR ® 56 DOS# 56 vildagliptin 56 OMP #M# 56 bicifadine 56 Elvitegravir 56 SinuNase TM 56 HCV protease 56 Aclidinium 56 Candesartan 56 myelofibrosis polycythemia vera 56 methylnaltrexone bromide 56 Tofacitinib 56 GGF2 56 immunomodulatory therapy 56 delta isoform 56 BRIM2 56 Campath ® 56 Ixabepilone 56 Targretin capsules 56 Interferon beta 56 Vaprisol 56 hypoxia selective 56 Romidepsin 56 familial hypercholesterolemia FH 56 hormone agonist 56 assessing T DM1 56 XOPENEX HFA 56 ZACTIMA 56 Frova ® 56 adipiplon 56 ReoPro 56 Cimzia TM 56 PD LID 56 MyVax personalized immunotherapy 56 ASONEP 56 5 fluorouracil leucovorin 56 Vilazodone 56 virus AAV 56 sitagliptin metformin 56 HSP# inhibitor 56 orally inhaled migraine 56 Microplasmin 56 highly selective endothelin 56 neuropathic pain metabolic diseases 56 #HT# 56 rALLy clinical trial 56 Aplidin 56 5 HT2C 56 Protelos R 56 perampanel 56 allosteric modulator NAM 56 CRTH2 56 Empatic TM 56 Sym# 56 timolol maleate 56 EP# [005] 56 vascular disrupting agent 56 DXL# 56 valopicitabine NM# 56 Bucindolol 56 CTAP# Injection 56 Carfilzomib 56 paclitaxel Taxol ® 56 Alequel ™ 56 Pradefovir 56 HyACT 56 buccal spray 56 TÎ ² 4 56 zotarolimus 56 psoriasis rheumatoid arthritis 56 Trastuzumab DM1 56 Genentech Rituxan 56 Aloxi injection 56 Fluconazole 56 squalamine 56 bioabsorbable polymer 56 Fluticasone 56 rosiglitazone maleate 56 2A receptor agonist 56 COPEGUS R 56 epoetin alpha 56 VEGFR2 inhibitor 56 Specifid 56 CytoFabTM 56 Posaconazole 56 Piperacillin 56 BXT # 56 Locked Nucleic Acid LNA 56 VA# [002] 56 MEK inhibitors 56 subcutaneous formulation 56 IgG1 monoclonal antibody 56 ADL# 56 ELND-#/AZD-# 56 Collategene 56 Bruton tyrosine kinase 56 anti CD3 monoclonal 56 Lubiprostone 56 Interferon beta 1a 56 NEUGENE 56 OHR/AVR# 56 Afinitor everolimus 56 Atrasentan 56 polysaccharide polymer 56 CCR5 inhibitor 56 prasugrel Effient 56 REP# 56 acting thrombolytic 56 Vascular Wrap 56 Occlusin TM 56 DCVax R 56 Pruvel 56 verteporfin 56 teduglutide 56 imatinib Gleevec ® 56 protein kinase inhibitor 56 Aptivus ® 56 XL# SAR# 56 essential thrombocythemia ET 56 Cand5 56 agonistic human 56 INCB# [003] 56 antiplatelet compound 56 tipifarnib 56 STEDESA 56 ionotropic glutamate receptor antagonists 56 Cytoxan ® 56 Tekamlo 56 epigenetic therapies 56 R bendamustine hydrochloride 56 Phase IIa Clinical Trial 56 candidate XP# 56 Factor Receptor 56 ATL# [001] 56 Bazedoxifene 56 TRC# 56 Symadex 56 Losartan 56 Gilead Viread 56 antibody MAb 56 Luramist 56 TRIOLEX ™ 56 targeted anticancer therapies 56 MB# MB# 56 RhuDex R 56 molecular chaperone regulator 56 microtubule inhibitor 56 Sevelamer 56 Wellstat 56 Rasilez Tekturna 56 OnDose 56 selective estrogen receptor modulator 56 SU# [003] 56 Galantamine 56 antisense oligonucleotide 56 Intravail R 56 Corlux 56 opioid receptor antagonist 56 Romiplostim 56 Enzastaurin 56 staphylococcal vaccine 56 Recombinant Human